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Abstract 
Background 
Asthma, wheeze and eczema are common in early childhood and cause considerable 
morbidity. Generally rates of these conditions are higher in high income compared to low 
income countries. Rates in developed nations are generally higher than in less developed 
countries. After migration to Western countries, differences in risks of developing these 
conditions may between migrant and non-migrant may diminish. 
Methods 
A convenience sample of 1648 children of White British, Pakistani or Other ethnicity aged 
between 4 and 5 years were recruited from the main Born in Bradford cohort. Children’s 
parents or guardians were asked to report on a range of potential risk factors and their 
associations with wheeze, asthma and eczema. Relationships between ethnicity and disease 
outcomes were examined using logistic regression after adjustment for other relevant risk 
factors and confounders. 
Results 
Ethnic differences in doctor diagnosed asthma were evident, with children of Other ethnic 
origin being less likely and children of Pakistani origin more likely to have a diagnosis than 
White British children, even after adjustment for other risk factors this difference only 
remained significant for the Other ethnic group. Ethnic differences were not observed in 
other outcomes including wheeze in the past 12 months, severe wheeze and taking 
medications for breathing problems. 
Conclusions 
In UK born children, traditional risk factors such as gender, family history, socio-economic 
status and child’s medical history may be stronger risk factors than ethnicity or familial 
migration patterns. 
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Ethnic and socio-economic differences in the prevalence of wheeze, severe wheeze, 
asthma, eczema and asthma related medication usage at 4 years of age: findings from the 
Born in Bradford birth cohort. 
 
Emily S Petherick, Neil Pearce, Jordi Sunyer, John Wright 
 
BACKGROUND 
Asthma, wheeze and eczema are common in early childhood and cause considerable 
morbidity. Globally wheeze and asthma prevalence in children aged 6-7 is generally highest 
in high income countries, with the prevalence of current wheeze being lowest in the Indian 
subcontinent and highest in English-speaking countries such as the United Kingdom and 
New Zealand [1]. Within Western countries, migrants generally have lower prevalence rates 
than native born populations [2]. However, the prevalence of wheeze and asthma 
symptoms may be higher in migrants compared to their peers in their countries of origin, 
and prevalence and severity increase with each additional year of residence in high-
prevalence countries [2-4]. The ethnic differences in eczema prevalence are not as 
consistent, with high prevalence observed in Western countries, such as the UK and NZ, but 
also high prevalence in some low and middle income countries in Africa and Latin America 
[5]. Similar to the situation with asthma, recent migrants to affluent and Western countries 
experience lower eczema prevalence than populations already resident in host countries [2]. 
The prevalence of physician-diagnosed asthma in childhood has been reported to differ by 
ethnicity in UK and other western populations. In the UK, highest rates have been reported 
in children of Black ethnicity followed by those of White and South Asian ethnicity [6]. 
Phenotypes of asthma, wheeze and atopy may also differ by ethnicity [7]. Atopy has also 
been shown to vary by ethnicity, with South Asian children having higher rates than their 
White British peers [8], although it is being increasingly recognised that not all persons who 
experience asthma, wheeze and/or eczema are also atopic [9,10]. Despite persons of South 
Asian origin resident in the UK being less likely to experience symptoms of wheeze and 
asthma, there are reports of poorer outcomes, with higher risks of exacerbations and 
hospitalisations [6,11,12]. South Asian populations resident in the United Kingdom (UK) are 
heterogeneous, originating from different countries including India, Pakistan and 
Bangladesh, experiencing differing cultural and socioeconomic profiles. Few studies of 
ethnic differences in childhood eczema have been reported. Lower eczema prevalence in 
children of Indian, Pakistani and Bangladeshi origin compared to children of White British 
origin has been reported in a London based study [3], whilst another prevalence study 
conducted in Leicester found no differences between White and Asian children [13]. The 
current study therefore examines the risks of wheeze, severe wheeze, doctor diagnosed 
asthma and eczema, and treatment provision for breathing problems, in an early childhood 
population that is UK born and predominantly of White British and Pakistani ethnic origin 
[14]. We also examine the comparability of these results to studies that have included 
heterogeneous South Asian populations with differing migration profiles [1,3,15]. 
 
2. Methods 
A sub-cohort of children from the Born in Bradford cohort study were recruited to 
participate in this study of asthma and allergy; this work was conducted as part of a larger 
EU FP7 project entitled Mechanisms of the Development of ALLergy (MeDALL) [16]. This 
subcohort consisted of a convenience sample of 1648 children aged between 4 and 5 years 
recruited between 22nd October 2012 and 24th April 2014 whose parented consented for 
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participation. Full details of the main Born in Bradford study and recruitment processes 
have been reported elsewhere [14]. Children's parents or guardians were asked to report on 
a range of potential risk factors and their associations with wheeze, asthma and atopy. 
Children's ethnicity was assigned based on maternal self-reported ethnicity and classified as 
White British, Pakistani and Other. We excluded responses from cases where maternal 
ethnicity was missing (excluded n = 2), resulting in an eligible study population of 1646 
children and their carers; which was predominantly their mother (n = 1621) or father (n = 
22). 
 
2.1. Clinical outcomes 
Wheeze: defined as self-reported wheeze in the past 12 months. Severe wheeze: defined as 
reported wheeze on four or more occasions in the past year. Asthma: defined as a positive 
report of doctor diagnosis of asthma ever. Eczema: defined as a positive report of ever been 
diagnosed by a physician with having eczema/atopic dermatitis. Medication use: defined as 
a positive response to question asking if child had received medication for asthma or other 
breathing problems during the previous 12 months. 
 
2.2. Statistical analysis 
The variables included in the analysis were based on previous literature, and in the case of 
socio-economic variables, were selected to ensure that a wide range were considered as our 
previous work in the cohort has shown that socio-economic measures and health 
behaviours may differ between different ethnic groups [17,18]. In particular, we considered 
adjusting for variables that have previously been shown to be associated with wheeze, 
asthma, eczema or medication usage in childhood. These included mothers age at delivery, 
maternal history of asthma or atopy (yes vs no), paternal history of asthma or atopy (yes vs 
no), maternal smoking during pregnancy (yes vs no), child currently exposed to smoke (yes 
vs no), visible signs of mould or damp in the home (yes vs no), gas cooker used in the home 
(no, yes always use an extractor fan, yes sometimes use a fan, yes never use a fan) mother 
born abroad (yes vs no), father born abroad (yes vs no), child seen doctor for chest infection 
in the past 12 months (yes vs no), born at term (yes vs no), gender of child (male vs female), 
ever breastfed (yes vs no), older sibling (yes vs no), birthweight (<2500g, 2500-2999g, 3000-
3499g, 3500-3999g, >=4000g), mode of birth (vaginal vs caesarean), ever eczema ever (yes 
vs no), ever had a problem with sneezing, or a runny or blocked nose when s/he did not 
have a cold or the flu (yes vs no) and mother's BMI at first pregnancy appointment with a 
midwife (booking). We included three different socio-economic indicators: highest maternal 
education level reported in the baseline questionnaire; (categorised as less than 5 General 
Certificates of Secondary Education (GCSEs), >5 GCSEs, A level, Degree Level, Other, Foreign 
Unknown or Other); current home ownership (yes vs no); and subjective poverty (yes vs no). 
Subjective poverty was derived by asking women how they felt they were managing 
financially and were classified as subjectively poor if they responded that they were “finding 
it very difficult” or “finding it quite difficult” and not subjectively poor if they responded that 
they were “living comfortably”, “doing alright” or “just getting by”. 
 
Comparison of characteristics between study participants of different ethnic backgrounds 
was performed using Chi square tests to investigate differences in proportions and ANOVA 
or Kruskall- Wallis tests to compare continuous data items. Univariate associations between 
covariables and outcomes were estimated using logistic regression. The optimal inclusion of 
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socioeconomic variables into final mutually adjusted models was determined by creating 
models with different combinations of socio-economic variables and calculating the 
Bayesian Information Criterion (BIC) to determine the most parsimonious model. The model 
with the lowest BIC value for each clinical outcome was chosen as the final model. All 
logistic regression analyses used complete case analysis only. Output from models was 
expressed as odds ratios and 95% confidence intervals of the effect estimates and 
corresponding p values provided. Estimates were assumed to indicated statistically 
significant differences if p values < 0.05. All analyses were conducted using Stata SE 14.1 
(Statacorp, Texas). 
 
3. Results 
The baseline characteristics of the participating mother-child pairs, by ethnicity, are shown 
in Table 1 below. Maternal and paternal history of asthma or atopy was more common in 
children of White British origin compared to Pakistani and Other ethnic groups. The Other 
ethnic group consisted of 60 Indian, 29 Bangladeshi, 25 White Other, 24 Black, 12 Mixed 
White and Black, 8 Mixed White and South Asian and 32 of Other ethnic background which 
included Arab and other Asian backgrounds which included Chinese and Philippino. 
Maternal smoking during pregnancy was higher in the White British group compared to the 
Other ethnic group and lowest in the Pakistani group. Current exposure to smoke in the 
home was higher in the Pakistani group compared to White British and lowest in the Other 
group. Women of Pakistani ethnicity were most likely to be in the normal weight category at 
booking. 
 
Insert table 1 here 
 
Socio-demographic characteristics differed between the different ethnic groups. Mother's 
age at delivery was youngest for mothers of Pakistani origin followed by mothers of Other 
ethnicity and of White British origin. Women in the Other ethnic group were more likely to 
have a degree or an A level education (or equivalent) followed by White British and 
Pakistani women. Mothers of Other ethnic origin were most likely to report that they were 
managing financially whilst White British mothers were least likely to report this. Mothers of 
Other ethnic origin were most likely to be born abroad compared to mothers of White 
British and Pakistani ethnic groups, whereas fathers of Pakistani children were most likely to 
born abroad compared to fathers of White British and Other ethnic origin. Rates of home 
ownership were highest amongst Pakistani respondents. 
 
There were also ethnic differences in specific household environmental risk factors; White 
British families were most likely to have gas cookers and use them without an extractor fan 
or only sometimes use an extractor fan, whilst children of Other ethnicities were slightly 
more likely to have visible damp in their homes. Children of Pakistani origin were more likely 
to have been born low or very low birth weight, delivered vaginally rather than via 
caesarean, and have an older sibling compared to White British and Other ethnic groups. 
Children of Other ethnic origin were most likely to have ever been breastfed, followed by 
Pakistani and lowest in the White British group. Minimal ethnic differences were observed 
between the prevalence of term birth. Eczema prevalence was highest in children of White 
British origin compared to children of other ethnic groups. 
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Table 2 below presents the patterns, by ethnicity, of all outcomes examined. Wheeze in the 
last 12 months was highest in children of Pakistani ethnicity, followed by children of White 
British and Other ethnic groups. In contrast, severe wheeze and eczema was highest in the 
White British group followed by those of Pakistani and Other ethnic background. Doctor 
diagnosis of asthma and medication usage for asthma or breathing problems was 
consistently highest in children of Pakistani origin followed by children of White British and 
then children of Other ethnic background. All potential confounders were explored in two 
different models for each outcome of interest. The first model (Table 3) examined the 
univariate associations between the various measures of socioeconomic position and all five 
outcomes; the second model mutually adjusted for all variables (Table 4). 
 
Insert table 2 here 
Insert table 3 here 
Insert table 4 here 
 
3.1. Wheeze in the past 12 months 
Mutual adjustment of variables showed that the odds of wheeze in the preceding 12 
months was higher if the child had eczema ever OR 1.71 (1.25-2.34), had a history of 
sneezing, runny or blocked nose when no cold 2.60 (1.88-3.61), has seen a doctor for a chest 
infection in the previous 12 months OR 7.29 (5.20-10.20), had a birthweight of less than 
2500 g OR 2.08 (1.17-3.69) or whether their mother had been overweight at the beginning 
of her pregnancy OR 1.44 (1.01-2.05). Additionally use of gas cooker was associated with 
elevated odds whether a gas cooker was used and also always used a fan OR 3.26 (1.48-
7.19), sometimes used a fan OR 3.09 (1.38-6.92) or never used a fan OR 2.72 (1.23-6.01). 
 
4. Severe wheeze 
Mutually adjusted models showed that the odds of severe wheeze were higher in children 
who reported sneezing, runny or blocked nose when no cold OR 3.97 (2.28-6.92) and 
reported of a doctor visit for chest infection OR 3.73 (2.10-6.61). Only if mothers place of 
birth had been abroad was there a lower odds of severe wheeze OR 0.24 (0.11-0.49). 
 
4.1. Doctor diagnosed asthma 
Odds of doctor diagnosed asthma were shown to be higher in children who reported ever 
sneezing, runny or blocked nose when not had a cold OR 2.02 (1.37-2.99), seen a doctor for 
a chest infection in the past 12 months OR 2.92 (1.97-4.34) and having a maternal history of 
asthma or atopy OR 1.82 (1.25-2.65) and eczema ever OR 2.08 (1.43-3.02) were all 
associated with higher odds of doctor diagnosed asthma. Reduced odds of asthma were 
only observed in girls compared to boys OR 0.56 (0.39-0.81) and children of Other ethnic 
group compared to White British OR 0.35 (0.13-0.96). Pakistani ethnicity was not statistically 
significantly associated with increased odds of doctor diagnosed asthma. 
 
4.2. Doctor diagnosed eczema 
Odds of doctor diagnosed eczema were higher in children who had problems with sneezing 
when didn't have a cold OR 1.83 (1.36-2.46), had a maternal history of asthma or atopy OR 
2.18 (1.67-2.84), were living in a home with visible signs of dampness or mould OR 1.37 
(1.02-1.85) or had been born via caesarean section OR 1.59 (1.17-2.15). Lower odds were 
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associated with having older siblings OR 0.60 (0.45-0.80) and being born <2500 g compared 
to 3000-3500 g OR 0.48 (0.27-0.85). 
 
4.3. Medications for asthma or breathing problems  
Having eczema ever OR 1.82 (1.33-2.50), ever sneezing or having a runny nose ever when 
not having a cold OR 2.58 (1.86-3.59), maternal history of asthma or atopy OR 1.52 (1.11-
2.08), having seen a doctor a chest infection in the previous 12 months OR 4.98 (3.55-7.00) 
and use of a gas cooker in the home whether always using an extractor fan OR 2.52 (1.18-
5.38), sometimes uses a fan OR 2.83 (1.30-6.15) or never uses a fan OR 2.40 (1.12e5.17) 
were all positively associated with medications for asthma or breathing problems. Female 
gender OR 0.66 (0.49-0.89) was however associated with a lower odds of receiving 
medications in line with the reduced risk of respiratory problems for girls. 
 
5. Discussion 
This study has found ethnic differences in the prevalence of doctor diagnosed asthma, with 
children of Other ethnicity less likely to receive a diagnosis than White British or Pakistani 
ethnicity children. However, no significant ethnic differences were observed for wheeze in 
the last 12 months, severe wheeze, doctor diagnosed eczema or taking medications for 
breathing problems or asthma, even after adjustment for other risk factors. For all five 
outcomes evaluated, one variable had consistent positive associations with outcomes: 
sneezing or having a runny nose ever when not having a cold and having whilst having seen 
a doctor for a chest infection in the previous 12 months was associated with higher odds of 
all outcomes with the exception of doctor diagnosed eczema. For most respiratory and 
respiratory medication usage outcomes, with the exception of severe wheeze, ever having 
eczema was associated with higher odds of these outcomes. Well established factors such 
as gender, family history, socioeconomic status and child's medical history and chest 
infection were found to be stronger risk factors than ethnicity for the outcomes examined. 
 
5.1. Strengths and weaknesses 
The strengths of our studies include the large sample size, a homogenous UK born Pakistani 
comparator group with a rich collection of socio-demographic and clinical data which has 
allowed for adjustment for a wide range of potential confounding factors. We were also 
able to adjust for multiple measures of socioeconomic status at different periods of the life-
course, an approach that has been recommended when examining health inequalities 
within and between ethnic groups [19e21]. We also adjusted for a wide range of factors 
relating to maternal and paternal migration in addition to ethnic background as well as 
other established risk factors for asthma and wheeze, although we were unable to adjust for 
pet ownership or day care attendance as this information was not collected. 
 
5.2. Strengths and weakness compared to other studies 
Our findings are consistent with results from the Millennium cohort study in finding no 
difference in wheeze between children of White British and Pakistani or Indian ethnic origin 
children [22] in the early years. Our findings of higher rates of doctor diagnosed asthma in 
Pakistani compared to White British children, although not achieving statistical significance, 
are similar to those of Panico et al. [22] who had used a definition of asthma ever. 
Irrespective of the definition used, results for asthma both from ours and earlier studies 
should be interpreted with caution given the diagnostic uncertainty of asthma in the age 
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groups under study. Our results are also based on a UK born Pakistani population which may 
also explain the similarity of some of our findings to those of Panico et al. [22]. With the 
exception of the current study and that of Panico et al. [22], previous studies of ethnic 
differences in wheeze, asthma and asthma treatment in the UK including Pakistani 
participants, analysed their data as part of a homogenous grouping of South Asian 
participants. A previous systematic review and meta-analysis of ethnic variations in asthma 
frequency and morbidity concluded that the prevalence of asthma and wheeze was lower in 
South Asian populations than observed for White children; however these studies were 
limited by the heterogeneity of ethnic groups included, and the lack of adjustment for 
migration status [11]. The other variable that is perhaps more likely to have influenced the 
lower prevalence results observed for South Asian children in the systematic review is the 
socio-economic profile of the included participants which will vary amongst and between 
different South Asian groups. South Asian women of Indian ethnic origin are more likely to 
be economically active compared to women of Pakistani and Bangladeshi ethnic 
backgrounds [23] and children of Bangladeshi and Pakistani origin are more likely to be 
economically deprived than Indian children [24]. Our findings for eczema are consistent with 
earlier findings in showing lower rates of eczema in children of Pakistani origin compared to 
White British children. Lower rates of eczema in Pakistani children are likely related to the 
lower rates of familial history and higher likelihood of being in a low socio-economic group, 
given previous consistent findings showing higher rates of eczema in offspring born to 
parents with asthma and/or eczema and those of higher socio-economic status [4,25,26]. 
We selected children for inclusion in this study based on their age based on those already 
participating in the overall Born in Bradford study. Compared to the main Born in Bradford 
study population [14] we have oversampled children of Pakistani ethnicity in this current 
subgroup which has enabled examination of parental migration effects. Whilst our results 
are likely representative of the Bradford district they may not be representative childhood 
populations in other UK cities. 
 
6. Conclusion 
The finding of a higher prevalence of doctor diagnosed asthma for Pakistani children in this 
young age group, in contrast with the lack of ethnic difference in asthma symptoms, may 
suggest greater medicalization of wheeze and respiratory symptomology for these children. 
The findings of the current study confirm the conclusions of the Millennium Cohort study 
[22], suggesting that associations between wheeze, asthma, eczema and medication usage 
for South Asian children are not homogenous. Authors of future studies should present 
results by different South Asian origin and report the migration status of the populations 
studied so that evidence generated will have greater validity and generalisability. 
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Table 1 Characteristics of study participants 
 White 
British 
Pakistani Other Total  
 495 (30.0) n=961 n=190 n=1646  
Family history      
Maternal history of 
asthma or atopy 
287 (58.0) 277 (28.8) 69 (36.3) 633 (38.5) <0.001 
Paternal history of 
asthma or atopy 
204 (41.2) 264 (27.5) 61 (32.1) 529 (32.1) <0.001 
Socio-demographic 
factors 
     
Maternal age at 
child’s birth 
29.2 (6.2) 28.6 (5.3) 29.1 (5.2) 28.8 (5.5) 0.13 
Maternal BMI at 
booking 
Underweight 
Normal 
Overweight 
Obese 
Missing 
 
 
3 (0.6) 
210 (42.4) 
129 (26.1) 
123 (24.9) 
30 (6.1) 
 
 
59 (6.1) 
429 (44.6) 
271 (28.2) 
150 (15.6) 
52 (5.4) 
 
 
4 (2.1) 
92 (48.4) 
53 (27.9) 
31 (16.3) 
10 (5.3) 
 
 
66 (4.0) 
731 (44.4) 
453 (27.5) 
304 (18.5) 
92 (5.6) 
 
 
 
 
 
 
<0.001 
Maternal education 
(baseline) 
<5 GCSEs 
5+ GCSEs 
A level 
Degree level 
Other 
Foreign 
unknown/Don’t 
know 
 
 
84 (17.0) 
150 (30.3) 
81 (16.4) 
127 (25.7) 
47 (9.5) 
6 (1.2) 
 
 
290 (30.2) 
290 (30.2) 
101 (10.5) 
247 (25.7) 
17 (1.8) 
12 (1.3) 
 
 
26 (13.7) 
44 (23.2) 
25 (13.2) 
65 (34.2) 
9 (4.7) 
20 (10.5) 
 
 
400 (24.3) 
484 (29.4) 
207 (12.6) 
439 (26.7) 
73 (4.4) 
38 (2.3) 
 
 
 
 
 
 
 
<0.001 
Housing tenure 
(current) 
Owns house 
 
 
291 (58.8) 
 
 
716 (74.5) 
 
 
110 (57.8) 
 
 
1117 (67.9) 
 
 
<0.001 
Subjectively poor 
(current) 
 
34 (6.87) 
 
49 (5.10) 
 
15 (7.89) 
 
98 (5.95) 
 
0.188 
Mother born abroad 
(baseline) 
Yes 
 
 
9 (1.8) 
 
 
645 (67.1) 
 
 
121 (63.7) 
 
 
775 (47.1) 
 
 
<0.001 
Father born abroad 
(baseline) 
Yes 
 
 
22 (4.4) 
 
 
572 (59.5) 
 
 
112 (59.0) 
 
 
706 (42.9) 
 
 
<0.001 
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Table 1 Characteristics of study participants (continued) 
 White 
British 
Pakistani Other Total  
Environmental 
exposures 
     
Currently exposed to 
smoke+ 
50 (10.1) 108 (11.2) 16 (8.4) 174 (10.6) 0.473 
Maternal smoked 
during pregnancy 
125 (25.3) 33 (3.4) 21 (9.3) 179 (10.9) <0.001 
Gas cooker in the 
home 
No 
Yes always use a fan 
Yes sometimes use a 
fan 
Yes never use a fan 
 
 
92 (18.6) 
138 (27.9) 
 
122 (24.7) 
143 (28.9) 
 
 
12 (1.3) 
498 (51.9) 
 
221 (23.0) 
230 (23.9) 
 
 
21 (11.1) 
70 (36.8) 
 
52 (27.4) 
47 (24.7) 
 
 
125 (7.6) 
706 (42.9) 
 
395 (24.0) 
420 (25.5) 
 
 
 
 
 
 
<0.001 
Visible signs of 
dampness or mould 
 
99 (20.0) 
 
206 (21.4) 
 
41 (21.6) 
 
346 (21.0) 
 
0.800 
Child characteristics      
Female gender 234 (47.2) 497 (51.7) 96 (50.5) 827 (50.2) 0.274 
Ever breastfed, yes 336 (67.9) 730 (76.0) 162 (85.3) 1228 (74.6) <0.001 
Seen doctor for 
chest infection past 
12 months 
 
 
52 (10.9) 
 
 
155 (16.9) 
 
 
22 (12.0) 
 
 
230 (14.5) 
 
 
0.029 
Older sibling* 261 (52.7) 627 (65.2) 108 (55.8) 996 (60.5) <0.000 
Eczema ever 177 (35.8) 227 (23.6) 49 (25.8) 453 (27.5) <0.000 
Ever sneezing, runny 
or blocked nose 
when no cold  
 
 
106 (21.4) 
 
 
178 (18.5) 
 
 
42 (22.1) 
 
 
326 (19.8) 
 
 
0.287 
Birth weight 
<2500 
2500-2999 
3000-3499 
3500-3999 
>4000 
 
27 (5.5) 
74 (15.0.) 
170 (34.3) 
145 (29.3) 
79 (16.0) 
 
104 (10.8) 
277 (28.8) 
342 (35.6) 
184 (19.2) 
54 (5.6) 
 
17 (9.0) 
46 (24.2) 
80 (42.1) 
35 (18.4) 
12 (6.3) 
 
148 (9.0) 
397 (24.1) 
592 (36.0) 
364 (22.1) 
145 (8.8) 
 
 
 
 
 
<0.000 
Term pregnancy, yes 437 (88.3) 833 (86.7) 166 (87.4) 1436 (87.2) 0.735 
Mode of birth 
Vaginal 
Caesarean 
 
379 (76.6) 
110 (22.2) 
 
755 (78.6) 
193 (20.1) 
 
141 (74.2) 
47 (24.7) 
 
1275 (77.5) 
350 (21.3) 
 
 
0.276 
Childs BMI z score, 
mean (SD) 
0.32 (0.97) 0.03 (1.23) 0.09 (1.12) 0.09 (1.15) <0.001 
+ Includes smoke exposure from mother, father or others in the home. 
 
Table 2 Summary of asthma, wheeze, eczema and medication usage by ethnic group 
 White 
British 
Pakistani Other Total  
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 n=495 n=961 n=190 n=1646 P value 
Wheeze  
Wheeze in the last 12 
months 
98 (19.8) 217 (22.6) 29 (15.3) 344 (20.9) 0.063 
Severe wheeze (>4 
times in a year)* 
31 (6.3) 39 (4.1) 4 (2.1) 74 (4.5) 0.014 
Asthma diagnosis and management  
Ever diagnosed by 
doctor as having 
asthma  
 
 
42 (8.9) 
 
 
129 (13.4) 
 
 
6 (3.2) 
 
 
179 (10.9) 
 
 
<0.001 
Ever diagnosed by 
doctor as having 
eczema or atopic 
dermatitis 
 
 
 
161 (32.5) 
 
 
 
200 (20.8) 
 
 
 
42 (22.1) 
 
 
 
403 (24.5) 
 
 
 
<0.001 
Taken medicines for 
asthma or breathing 
difficulties in past 12 
months 
 
 
 
94 (19.0) 
 
 
 
185 (19.3) 
 
 
 
23 (12.1) 
 
 
 
302 (18.3) 
 
 
 
0.065 
*Denominator participants that reported wheezing or whistling in the last 12 months. 
+Denominator 164 participants with valid atopy and ethnicity data 
 
Table 3 Associations of socio-economic measures with outcomes 
 Wheeze in 
the last 12 
months 
Severe 
Wheeze 
Doctor 
diagnosed 
asthma 
Doctor 
diagnosed 
eczema 
Medications 
for asthma or 
breathing 
problems 
Maternal 
Education 
<5 GCSEs 
 
5+ GCSEs 
A level 
 
Degree level 
 
Other 
 
Foreign 
unknown/Don’t 
know 
 
 
0.90  
(0.65-1.24) 
1 
0.86  
(0.58-1.28) 
0.70 
(0.51-0.97)* 
1.07 
(0.61-1.90) 
0.62 
(0.25-1.51) 
 
 
1.09  
(0.57-2.10) 
1 
1.05  
(0.47-2.36) 
1.05  
(0.55-1.99) 
1.70  
(0.62-4.70) 
1.29  
(0.29-5.73) 
 
 
1.13  
(0.77-1.67) 
1 
0.53  
(0.29-0.96)* 
0.52  
(0.32-0.81)* 
0.96  
(0.45-2.02) 
1.03  
(0.39-2.74) 
 
 
0.76  
(0.55-1.04) 
1 
1.15  
(0.80-1.67) 
1.08  
(0.80-1.45) 
1.14  
(0.66-1.99) 
0.94  
(0.43-2.04) 
 
 
0.91  
(0.65-1.27) 
1 
0.89  
(0.58-1.34) 
0.71  
(0.51-1.01) 
1.20  
(0.67-2.15) 
0.89  
(0.38-2.08) 
Subjectively 
poor, yes  
2.21  
(1.44-3.41)* 
1.15  
(0.45-2.91) 
1.79  
(1.03-3.09)* 
1.25  
(0.79-1.96) 
1.56  
(0.97-2.50) 
Housing tenure  
Owns house, 
yes 
 
0.65  
(0.51-0.83)** 
 
0.45 
(0.29-0.72)** 
 
0.66 
(0.48-0.90)** 
 
0.94 
(0.74-1.19) 
 
0.69 
(0.53-0.89)** 
* p<0.05, ** p<0.001, *** p <0.0001 
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Table 4 Unadjusted and Adjusted associations with study outcomes+ 
 Wheeze in the last 12 
months 
Severe Wheeze Doctor diagnosed asthma Doctor diagnosed eczema Medications for asthma or 
breathing problems 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Ethnicity 
White British 
Pakistani 
 
Other 
 
1 
1.18  
(0.90-1.54) 
0.73  
(0.47-1.16) 
 
1 
0.98 
(0.60-1.61) 
0.57      
(0.30-1.09) 
 
1 
0.63  
(0.39-1.03) 
0.32  
(0.11-0.92) 
 
1 
0.92      
(0.39-2.16) 
0.47      
(0.14-1.60) 
 
1 
1.59* 
(1.11-2.28) 
0.33* 
(0.14-0.80) 
 
1 
1.84  
(0.99-3.44) 
0.35* 
(0.13-0.96) 
 
1 
0.55*** 
(0.43-0.70) 
0.59** 
(0.40-0.87) 
 
1 
0.79      
(0.52-1.22) 
0.68      
(0.40-1.16) 
 
1 
1.02 (0.77-
1.34) 
0.59* 
(0.36-0.97) 
 
1 
1.22      
(0.73-2.01) 
0.67      
(0.35-1.29) 
Female gender 0.77* 
(0.60-0.96) 
0.75      
(0.56-1.00) 
0.88  
(0.55-1.41) 
0.96      
(0.57-1.63) 
0.64 (0.46-
0.87)** 
0.56**   
(0.39-0.81) 
0.97  
(0.77-1.21) 
1.01      
(0.78-1.29) 
0.67** 
(0.52-0.86) 
0.66**   
(0.49-0.89) 
Eczema ever 1.96* 
(1.53-2.52) 
1.71***  
(1.25-2.34) 
1.85* 
(1.49-2.98) 
1.35 
(0.77-2.38) 
2.43*** 
(1.77-3.34) 
2.08***  
(1.43-3.02) 
- - 2.26*** 
(1.75-2.94) 
1.82***  
(1.33-2.50) 
Ever sneezing, 
runny or 
blocked nose 
when no cold  
2.76 
(2.11-3.60)* 
2.60***  
(1.88-3.61) 
3.51 *** 
(2.18-5.64) 
 
3.97***  
(2.28-6.92) 
2.42 *** 
(1.73-3.39) 
2.02***  
(1.37-2.99) 
2.06 *** 
(1.59-2.67) 
1.83***  
(1.36-2.46) 
2.89 *** 
(2.19-3.81) 
2.58***  
(1.86-3.59) 
Older sibling 0.80  
(0.62-1.02) 
0.78      
(0.55-1.10) 
0.56* 
(0.35-0.89) 
0.82      
(0.44-1.53) 
0.87  
(0.63-1.20) 
1.01      
(0.66-1.54) 
0.61*** 
(0.49-0.77) 
0.60***  
(0.45-0.80) 
0.72* 
(0.56-0.93) 
0.72      
(0.51-1.02) 
Maternal age 
at child’s birth 
15-19 
 
20-24 
 
25-29 
 
30-34 
 
35+ 
 
 
1.07  
(0.57-2.01) 
1.13  
(0.82-1.56) 
1 
 
1.01  
(0.73-1.39) 
0.97  
(0.67-1.41) 
 
 
0.93      
(0.42-2.07) 
1.13      
(0.75-1.70) 
1 
 
1.19      
(0.79-1.77) 
1.23      
(0.78-1.93) 
 
 
2.51  
(1.09-5.77) 
0.88  
(0.48-1.62) 
1 
 
0.54  
(0.27-1.07) 
0.57  
(0.26-1.26) 
 
 
1.32      
(0.46-3.82) 
0.65 
(0.32-1.33) 
1 
 
0.53      
(0.23-1.20) 
0.70      
(0.29-1.70) 
 
 
1.72  
(0.85-3.48) 
1.21  
(0.81-1.83) 
1 
 
0.77  
(0.49-1.20) 
1.10  
(0.69-1.76) 
 
 
1.52      
(0.62-3.73) 
1.18      
(0.72-1.93) 
1 
 
0.85      
(0.51-1.41) 
1.27      
(0.73-2.22) 
 
 
1.05  
(0.59-1.90) 
0.99  
(0.73-1.34) 
1 
 
0.88  
(0.64-1.18) 
0.99  
(0.70-1.40) 
 
 
0.76      
(0.38-1.52) 
0.88      
(0.62-1.26) 
1 
 
0.98 
(0.69-1.39) 
1.01 
(0.68-1.50) 
 
 
1.19  
(0.63-2.24) 
1.04  
(0.75-1.46) 
1 
 
0.84  
(0.59-1.18) 
1.00  
(0.69-1.47) 
 
 
0.90      
(0.41-2.00) 
0.87 
(0.57-1.32) 
1 
 
0.84  
(0.56-1.27) 
1.07      
(0.68-1.70) 
+For wheeze in the past 12 months subjective poverty increased the odds by 2.10 (1.20-3.66)**, owning compared to renting your house was associated with a reduced 
odds of severe wheeze OR 0.49 (0.27-0.89)*, doctor diagnosed asthma OR 0.62 (0.41-0.93)*. Housing tenure was not statistically significantly associated with medication 
for asthma or breathing problems OR 0.71 (0.51-1.00) whilst for doctor diagnosed eczema none of the socio-economic measures evaluated improved model fit so none 
were included in final models. 
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Table 4 Unadjusted and Adjusted relationship with study outcomes (continued) 
 Wheeze in the last 12 
months 
Severe Wheeze Doctor diagnosed asthma Doctor diagnosed eczema Medications for asthma or 
breathing problems 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Family history           
Maternal 
history of 
asthma or 
atopy 
1.43* 
(1.13-1.82) 
1.11      
(0.81-1.52) 
1.94* 
(1.22-3.10) 
1.12      
(0.64-1.96) 
1.72** 
(1.26-2.35) 
1.82**   
(1.25-2.65) 
2.48*** 
(1.97-3.12) 
2.18***  
(1.67-2.84) 
1.82*** 
(1.41-2.34) 
1.52**   
(1.11-2.08) 
Paternal 
history of 
asthma or 
atopy 
1.09  
(0.85-1.41) 
1.15      
(0.84-1.57) 
1.08  
(0.66-1.77) 
0.88      
(0.48-1.58) 
1.34  
(0.97-1.84) 
1.41      
(0.96-2.05) 
1.52*** 
(1.20-1.92) 
1.25      
(0.96-1.64) 
1.18  
(0.90-1.53) 
1.16      
(0.85-1.60) 
Maternal 
smoking during 
pregnancy 
1.23  
(0.85-1.77) 
1.24      
(0.75-2.04) 
1.29  
(0.65-2.57) 
0.51      
(0.22-1.21) 
0.90  
(0.54-1.51) 
0.93      
(0.48-1.80) 
1.08  
(0.76-1.54) 
0.75      
(0.48-1.18) 
1.05  
(0.70-1.55) 
0.81      
(0.48-1.38) 
Currently 
exposed to 
smoke 
1.19  
(0.82-1.72) 
1.14      
(0.73-1.79) 
1.87* 
(1.00-3.47) 
1.93      
(0.92-4.06) 
1.21  
(0.75-1.95) 
1.14      
(0.66-1.94) 
1.09  
(0.76-1.56) 
1.12      
(0.75-1.68) 
1.00  
(0.67-1.50) 
0.89      
(0.55-1.44) 
Mother born 
abroad 
(baseline) 
Yes 
0.98  
(0.78-1.25) 
0.84      
(0.59-1.21) 
0.32*** 
(0.18-0.56) 
0.24***  
(0.11-0.49) 
1.25  
(0.91-1.70) 
1.22      
(0.78-1.90) 
0.65*** 
(0.51-0.81) 
0.88      
(0.63-1.22) 
0.88  
(0.68-1.13) 
0.84      
(0.58-1.22) 
Father born 
abroad vs UK 
born (baseline) 
1.19  
(0.94-1.51) 
1.38      
(0.97-1.95) 
0.85  
(0.52-1.37) 
1.16      
(0.57-2.35) 
1.33  
(0.97-1.81) 
1.39      
(0.91-2.12) 
0.71** 
(0.56-0.90) 
0.93      
(0.68-1.27) 
1.13  
(0.88-1.45) 
1.26      
(0.88-1.81) 
Seen doctor for 
chest infection 
past 12 months 
7.77*** 
(5.77-10.45) 
7.29***  
(5.20-10.2) 
4.22*** 
(2.59-6.89) 
3.73***  
(2.10-6.61) 
4.03*** 
(2.89-5.70) 
2.92***  
(1.97-4.34) 
1.56** 
(1.16-2.11) 
1.38      
(0.98-1.95) 
5.74*** 
(4.27-7.73) 
4.98***  
(3.55-7.00) 
Visible signs of 
dampness or 
mould 
1.18  
(0.89-1.57) 
1.11      
(0.78-1.58) 
1.13  
(0.65-1.96) 
0.82      
(0.45-1.50) 
0.98  
(0.67-1.44) 
0.80      
(0.51-1.24) 
1.34* 
(1.03-1.74) 
1.37*    
(1.02-1.85) 
1.23  
(0.91-1.65) 
0.77      
(0.54-1.09) 
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Table 4 Unadjusted and Adjusted relationship with study outcomes (continued) 
 Wheeze in the last 12 
months 
Severe Wheeze Doctor diagnosed asthma Doctor diagnosed eczema Medications for asthma or 
breathing problems 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Gas cooker in 
the home 
No 
Yes always use 
a fan 
Yes sometimes 
use a fan 
Yes never use a 
fan 
 
 
1 
1.98* 
(1.14-3.44) 
1.70  
(0.95-3.04) 
1.86* 
(1.05-3.31) 
 
 
1 
3.26**    
(1.48-7.19) 
3.09**    
(1.38-6.92) 
2.72*     
(1.23-6.01) 
 
 
1 
1.21  
(0.47-3.17) 
1.28  
(0.47-3.48) 
0.89  
(0.31-2.50) 
 
 
1 
2.46     
(0.73-8.30) 
3.25     
(0.92-11.5) 
1.21     
(0.34-4.27) 
 
 
1 
1.58  
(0.77-3.24) 
1.37  
(0.64-2.92) 
1.95  
(0.93-4.06) 
 
 
1 
1.92      
(0.72-5.11) 
2.15      
(0.79-5.87) 
2.51      
(0.95-6.66) 
 
 
1 
0.66  
(0.44-1.00) 
0.67  
(0.43-1.04) 
0.77  
(0.50-1.20) 
 
 
1 
0.76     
(0.46-1.26) 
0.68     
(0.40-1.14) 
0.81     
(0.49-1.35) 
 
 
1 
1.58  
(0.91-2.76) 
1.52  
(0.85-2.72) 
1.63  
(0.92-2.91) 
 
 
1 
2.52*    
(1.18-5.38) 
2.83**   
(1.30-6.15) 
2.40*    
(1.12-5.17) 
Child 
characteristics 
          
Birth weight 
<2500 
 
2500-2999 
 
3000-3499 
3500-3999 
 
>4000 
 
1.63* 
(1.09-2.44) 
1.02  
(0.75-1.40) 
1 
0.90  
(0.65-1.25) 
0.84  
(0.53-1.35) 
 
2.08*     
(1.17-3.69) 
1.02      
(0.69-1.51) 
1 
0.80      
(0.54-1.19) 
0.69      
(0.37-1.30) 
 
2.18  
(1.09-4.38) 
0.77  
(0.39-1.52) 
1 
1.18  
(0.63-2.19) 
0.81  
(0.30-2.15) 
 
2.07     
(0.79-5.46) 
0.83     
(0.37-1.84) 
1 
1.33     
(0.66-2.69) 
0.98     
(0.32-2.95) 
 
1.39  
(0.81-2.38) 
1.05  
(0.69-1.60) 
1 
1.19  
(0.78-1.80) 
0.95  
(0.51-1.75) 
 
1.77      
(0.88-3.56) 
1.05      
(0.65-1.70) 
1 
1.20      
(0.75-1.92) 
0.87      
(0.39-1.97) 
 
0.79  
(0.51-1.23) 
0.87  
(0.64-1.17) 
1 
1.03  
(0.76-1.39) 
1.22  
(0.82-1.83) 
 
0.48*    
(0.27-0.85) 
0.88     
(0.63-1.23) 
1 
0.90     
(0.64-1.27) 
1.16     
(0.71-1.90) 
 
1.58* 
(1.03-2.43) 
0.93  
(0.66-1.31) 
1 
1.05  
(0.75-1.48) 
1.29  
(0.82-2.03) 
 
1.52      
(0.84-2.73) 
0.90      
(0.60-1.36) 
1 
1.09      
(0.73-1.62) 
1.44      
(0.80-2.58) 
Child BMI z 
score 
1.04  
(0.94-1.16) 
1.06      
(0.93-1.22) 
1.02  
(0.83-1.25) 
0.99     
(0.77-1.28) 
1.05 
(0.92, 1.20)  
1.09      
(0.93-1.28) 
1.03  
(0.93-1.13) 
0.95     
(0.85-1.08) 
1.03  
(0.92-1.15) 
1.04      
(0.90-1.19) 
Term 
pregnancy  
0.56** 
(0.40-0.79) 
0.91      
(0.56-1.49) 
0.45* 
(0.26-0.81) 
0.59     
(0.26-1.35) 
0.81  
(0.51-1.28) 
1.00      
(0.54-1.83) 
0.81  
(0.58-1.14) 
0.65     
(0.41-1.03) 
0.54** 
(0.38-0.77) 
0.70      
(0.43-1.15) 
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Table 4 Unadjusted and Adjusted relationship with study outcomes (continued) 
 Wheeze in the last 12 
months 
Severe Wheeze Doctor diagnosed asthma Doctor diagnosed eczema Medications for asthma or 
breathing problems 
 Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted Unadjusted Adjusted 
Ever breastfed 0.93      
(0.71-1.22) 
0.97   
(0.69-1.38) 
0.74         
(0.45-1.23) 
0.84         
(0.46-1.54) 
0.86  
(0.61-1.22) 
0.86       
(0.57-1.30) 
1.18  
(0.91-1.54) 
0.77      
(0.54-1.09) 
0.90  
(0.68-1.19) 
0.77      
(0.54-1.09) 
Mode of birth 
Vaginal 
Caesarean 
 
1 
1.11      
(0.83-1.47) 
 
1 
1.00   
(0.70-1.43) 
 
1 
1.10         
(0.58-2.10) 
 
1 
1.08      
(0.56-2.05) 
 
1 
1.05  
(0.72-1.54) 
 
1 
1.00      
(0.64-1.55) 
 
1 
1.54  
(1.19-2.00) 
 
1 
1.59**    
(1.17-2.15) 
 
1 
1.21  
(0.90-1.63) 
 
1 
1.09      
(0.76-1.56) 
Maternal BMI 
at booking 
Underweight 
 
Normal 
Overweight 
 
Obese 
 
 
1.31      
(0.71-2.40) 
1 
1.34      
(1.01-1.79)* 
1.33      
(0.96-1.84) 
 
 
1.35  
(0.64-2.86) 
1 
1.44*  
(1.01-2.05) 
1.39  
(0.92-2.09) 
 
 
2.62         
(0.82-8.37) 
1 
1.17         
(0.60-2.28) 
0.96         
(0.45-2.05) 
 
 
2.68      
(0.84-8.55) 
1 
1.16      
(0.60-2.25) 
0.96      
(0.46-2.04) 
 
 
0.96  
(0.43-2.18) 
1 
0.99  
(0.68-1.44) 
0.99  
(0.64-1.52) 
 
 
0.66      
(0.25-1.73) 
1 
0.93      
(0.60-1.44) 
0.95      
(0.57-1.57) 
 
 
0.93  
(0.52-1.67) 
1 
0.89  
(0.68-1.17) 
0.90  
(0.66-1.23) 
 
 
1.24      
(0.65-2.37) 
1 
0.86      
(0.63-1.17) 
0.79      
(0.55-1.14) 
 
 
1.20  
(0.63-2.27) 
1 
1.13  
(0.83-1.53) 
1.23  
(0.87-1.72) 
 
 
0.98      
(0.45-2.16) 
1 
1.19      
(0.83-1.71) 
1.12      
(0.74-1.70) 
* p<0.05, ** p<0.001, *** p <0.0001 
 
17 
 
REFERENCES 
 
1  Lai CKW, Beasley R, Crane J, et al. Global variation in the prevalence and severity of 
asthma symptoms: phase three of the International Study of Asthma and Allergies in 
Childhood (ISAAC). Thorax 2009;64:476–83. doi:10.1136/thx.2008.106609 
2  Garcia-Marcos L, Robertson CF, Ross Anderson H, et al. Does migration affect asthma, 
rhinoconjunctivitis and eczema prevalence? Global findings from the international 
study of asthma and allergies in childhood. Int J Epidemiol 2014;43:1846–54. 
doi:10.1093/ije/dyu145 
3  Whitrow MJ, Harding S. Asthma in Black African, Black Caribbean and South Asian 
adolescents in the MRC DASH study: a cross sectional analysis. BMC Pediatr 
2010;10:18. doi:10.1186/1471-2431-10-18 
4  Cabieses B, Uphoff E, Pinart M, et al. A systematic review on the development of 
asthma and allergic diseases in relation to international immigration: the leading role 
of the environment confirmed. PLoS One 2014;9:e105347. 
doi:10.1371/journal.pone.0105347 
5  Odhiambo JA, Williams HC, Clayton TO, et al. Global variations in prevalence of 
eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 
2009;124:1251–8.e23. doi:10.1016/j.jaci.2009.10.009 
6  Davidson E, Liu JJ, Sheikh A. The impact of ethnicity on asthma care. Prim Care Respir 
J 2010;19:202–8. doi:10.4104/pcrj.2010.00013 
7  Kelley CF, Mannino DM, Homa DM, et al. Asthma phenotypes, risk factors, and 
measures of severity in a national sample of US children. Pediatrics 2005;115:726–31. 
doi:10.1542/peds.2004-0529 
8  Carey OJ, Cookson JB, Britton J, et al. The effect of lifestyle on wheeze, atopy, and 
bronchial hyperreactivity in Asian and white children. Am J Respir Crit Care Med 
1996;154:537–40. doi:10.1164/ajrccm.154.2.8756835 
9  Brown S, Reynolds NJ. Atopic and non-atopic eczema. BMJ 2006;332:584–8. 
doi:10.1136/bmj.332.7541.584 
10  Court CS, Cook DG, Strachan DP. Comparative epidemiology of atopic and non-atopic 
wheeze and diagnosed asthma in a national sample of English adults. Thorax 
2002;57:951–7. 
11  Netuveli G, Hurwitz B, Levy M, et al. Ethnic variations in UK asthma frequency, 
morbidity, and health-service use: a systematic review and meta-analysis. Lancet 
(London, England);365:312–7. doi:10.1016/S0140-6736(05)17785-X 
12  Sheikh A, Steiner MFC, Cezard G, et al. Ethnic variations in asthma hospital admission, 
readmission and death: a retrospective, national cohort study of 4.62 million people 
in Scotland. BMC Med 2016;14:3. doi:10.1186/s12916-015-0546-6 
13  Neame RL, Berth-Jones J, Kurinczuk JJ, et al. Prevalence of atopic dermatitis in 
Leicester: a study of methodology and examination of possible ethnic variation. Br J 
Dermatol 1995;132:772–7. 
14  Wright J, Small N, Raynor P, et al. Cohort profile: The born in bradford multi-ethnic 
family cohort study. Int J Epidemiol 2013;42:978–91. doi:10.1093/ije/dys112 
15  Netuveli G, Hurwitz B, Sheikh A. Ethnic variations in incidence of asthma episodes in 
England & Wales: national study of 502,482 patients in primary care. Respir Res 
2005;6:120. doi:10.1186/1465-9921-6-120 
18 
 
16  Bousquet J, Anto J, Auffray C, et al. MeDALL (Mechanisms of the Development of 
ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 
2011;66:596–604. doi:10.1111/j.1398-9995.2010.02534.x 
17  Fairley L, Cabieses B, Small N, et al. Using latent class analysis to develop a model of 
the relationship between socioeconomic position and ethnicity: cross-sectional 
analyses from a multi-ethnic birth cohort study. BMC Public Health 2014;14:835. 
doi:10.1186/1471-2458-14-835 
18  West J, Lawlor DA, Fairley L, et al. Differences in socioeconomic position, lifestyle and 
health-related pregnancy characteristics between Pakistani and White British women 
in the Born in Bradford prospective cohort study: the influence of the woman’s, her 
partner's and their parents' place . BMJ Open 2014;4:e004805. doi:10.1136/bmjopen-
2014-004805 
19  Krieger N. A glossary for social epidemiology. J Epidemiol Community Health 
2001;55:693–700. 
20  Galobardes B, Shaw M, Lawlor DA, et al. Indicators of socioeconomic position (part 1). 
J Epidemiol Community Health 2006;60:7–12. doi:10.1136/jech.2004.023531 
21  Galobardes B, Shaw M, Lawlor DA, et al. Indicators of socioeconomic position (part 2). 
J Epidemiol Community Health 2006;60:95–101. doi:10.1136/jech.2004.028092 
22  Panico L, Bartley M, Marmot M, et al. Ethnic variation in childhood asthma and 
wheezing illnesses: findings from the Millennium Cohort Study. Int J Epidemiol 
2007;36:1093–102. doi:10.1093/ije/dym089 
23  Dale A. A Life-course Perspective on Ethnic Differences in Women’s Economic Activity 
in Britain. Eur Sociol Rev 2006;22:323–37. doi:10.1093/esr/jci060 
24  Platt. L. JRF programme paper: Poverty and ethnicity, Inequality within ethnic groups. 
Joseph Rowntree Foundation, York 2011.  
25  Bisgaard H, Halkjaer LB, Hinge R, et al. Risk analysis of early childhood eczema. J 
Allergy Clin Immunol 2009;123:1355–60.e5. doi:10.1016/j.jaci.2009.03.046 
26  Purvis DJ, Thompson JMD, Clark PM, et al. Risk factors for atopic dermatitis in New 
Zealand children at 3.5 years of age. Br J Dermatol 2005;152:742–9. 
doi:10.1111/j.1365-2133.2005.06540.x 
 
